These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A second class of nuclear receptors for oxysterols: Regulation of RORalpha and RORgamma activity by 24S-hydroxycholesterol (cerebrosterol). Wang Y; Kumar N; Crumbley C; Griffin PR; Burris TP Biochim Biophys Acta; 2010 Aug; 1801(8):917-23. PubMed ID: 20211758 [TBL] [Abstract][Full Text] [Related]
6. Discovery of biaryls as RORγ inverse agonists by using structure-based design. Enyedy IJ; Powell NA; Caravella J; van Vloten K; Chao J; Banerjee D; Marcotte D; Silvian L; McKenzie A; Hong VS; Fontenot JD Bioorg Med Chem Lett; 2016 May; 26(10):2459-2463. PubMed ID: 27080181 [TBL] [Abstract][Full Text] [Related]
7. Discovery of 1-{4-[3-fluoro-4-((3s,6r)-3-methyl-1,1-dioxo-6-phenyl-[1,2]thiazinan-2-ylmethyl)-phenyl]-piperazin-1-yl}-ethanone (GNE-3500): a potent, selective, and orally bioavailable retinoic acid receptor-related orphan receptor C (RORc or RORγ) inverse agonist. Fauber BP; René O; Deng Y; DeVoss J; Eidenschenk C; Everett C; Ganguli A; Gobbi A; Hawkins J; Johnson AR; La H; Lesch J; Lockey P; Norman M; Ouyang W; Summerhill S; Wong H J Med Chem; 2015 Jul; 58(13):5308-22. PubMed ID: 26061388 [TBL] [Abstract][Full Text] [Related]
9. Discovery of novel N-sulfonamide-tetrahydroquinolines as potent retinoic acid receptor-related orphan receptor γt inverse agonists for the treatment of autoimmune diseases. Sun N; Ma X; Zhou K; Zhu C; Cao Z; Wang Y; Xu J; Fu W Eur J Med Chem; 2020 Feb; 187():111984. PubMed ID: 31881455 [TBL] [Abstract][Full Text] [Related]
10. Structure-based design of substituted hexafluoroisopropanol-arylsulfonamides as modulators of RORc. Fauber BP; de Leon Boenig G; Burton B; Eidenschenk C; Everett C; Gobbi A; Hymowitz SG; Johnson AR; Liimatta M; Lockey P; Norman M; Ouyang W; René O; Wong H Bioorg Med Chem Lett; 2013 Dec; 23(24):6604-9. PubMed ID: 24239186 [TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of azole-type fungicides on interleukin-17 gene expression via retinoic acid receptor-related orphan receptors α and γ. Kojima H; Muromoto R; Takahashi M; Takeuchi S; Takeda Y; Jetten AM; Matsuda T Toxicol Appl Pharmacol; 2012 Mar; 259(3):338-45. PubMed ID: 22289359 [TBL] [Abstract][Full Text] [Related]
13. Endogenously produced nonclassical vitamin D hydroxy-metabolites act as "biased" agonists on VDR and inverse agonists on RORα and RORγ. Slominski AT; Kim TK; Hobrath JV; Oak ASW; Tang EKY; Tieu EW; Li W; Tuckey RC; Jetten AM J Steroid Biochem Mol Biol; 2017 Oct; 173():42-56. PubMed ID: 27693422 [TBL] [Abstract][Full Text] [Related]
14. ROR inverse agonist suppresses insulitis and prevents hyperglycemia in a mouse model of type 1 diabetes. Solt LA; Banerjee S; Campbell S; Kamenecka TM; Burris TP Endocrinology; 2015 Mar; 156(3):869-81. PubMed ID: 25560829 [TBL] [Abstract][Full Text] [Related]
15. Development of novel silicon-containing inverse agonists of retinoic acid receptor-related orphan receptors. Toyama H; Nakamura M; Nakamura M; Matsumoto Y; Nakagomi M; Hashimoto Y Bioorg Med Chem; 2014 Mar; 22(6):1948-59. PubMed ID: 24559867 [TBL] [Abstract][Full Text] [Related]
16. The ROR nuclear orphan receptor subfamily: critical regulators of multiple biological processes. Jetten AM; Kurebayashi S; Ueda E Prog Nucleic Acid Res Mol Biol; 2001; 69():205-47. PubMed ID: 11550795 [TBL] [Abstract][Full Text] [Related]
17. A reversed sulfonamide series of selective RORc inverse agonists. van Niel MB; Fauber BP; Cartwright M; Gaines S; Killen JC; René O; Ward SI; de Leon Boenig G; Deng Y; Eidenschenk C; Everett C; Gancia E; Ganguli A; Gobbi A; Hawkins J; Johnson AR; Kiefer JR; La H; Lockey P; Norman M; Ouyang W; Qin A; Wakes N; Waszkowycz B; Wong H Bioorg Med Chem Lett; 2014 Dec; 24(24):5769-5776. PubMed ID: 25453817 [TBL] [Abstract][Full Text] [Related]